-
-
-
-
-
-
-
American Cancer Society reaffirms Abbott colorectal screening tests
-
-
-
-
-
-
-
Abbott Labs (ABT) PT Lowered to $110 at Bernstein SocGen Group
-
-
-
-
-
-
-
Abbott shares dip on soft current-quarter guide; Q1 results in line
-
-
-
-
-
-
-
Abbott Labs (ABT) Reiterated at Buy by Benchmark After FreeDM Trial Results
-
-
-
-
-
-
-
Increasing unusual put option volume: TRIP ABT GTM SAP URI COPX KOS XRX SYK INTU
-
-
-
-
-
-
-
Benchmark Reiterates Buy Rating on Abbott Labs (ABT): Annual Estimates Unchanged
-
-
-
-
-
-
-
Increasing unusual put option volume: IBRX HSBC CRVS KBE HWM HBAN NUAI SEI COPX PSX ABT
-
428,352 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

